Desk› Healthcare› Jagsonpal Pharmaceuticals Ltd

Jagsonpal Pharmaceuticals Ltd

BSE 507789 JAGSNPHARM INE048B01035

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Filing rhythm · 30 trading days

16 filings · 6 material · busiest 2026-07-29

What it files

ESOP Allotment3 Newspaper Publication2 Analyst / Investor Meet2 Concall Transcript1 Board Outcome1 Results1 Investor Presentation1 Press Release1

Filings

16 in the window

24 August 2026

ESOP Allotment

Allotment of ESOP / ESPS

Allotment of 27950 Equity Shares under the Jagsonpal Pharmaceuticals Limited Employee stock option Plan 2022

Company Update / Allotment of ESOP / ESPS View filing →
12 August 2026

Newspaper Publication

Newspaper Publication

Newspaper Advertisement- 47th Annual General Meeting of the Company to be held on September 18, 2026

Company Update / Newspaper Publication View filing →
4 August 2026

Concall Transcript

Earnings Call Transcript

Earning Call Transcript for meeting held on July 30, 2026

Company Update / Earnings Call Transcript View filing →
30 July 2026

Newspaper Publication

Newspaper Publication

Newspaper Publication of Unaudited Financial Results of the Company for the quarter ended June 30, 2026

Company Update / Newspaper Publication View filing →
30 July 2026

Analyst / Investor Meet

Analyst / Investor Meet - Outcome

Audio Recording of Jagsonpal Pharmaceuticals Limited Q1 FY27 Earnings Conference Call on July 30, 2026 at 2:30 P.M.

Company Update / Analyst / Investor Meet View filing →
29 July 2026

Board Outcome

Board Meeting Outcome for Outcome Of Board Meeting Held On July 29, 2026 Along With Unaudited (Standalone) Financial Results For The Quarter June 30, 2026

Outcome of Board Meeting held on July 29, 2026 along with Unaudited (Standalone) Financial Results for the quarter June 30, 2026

Board Meeting / Outcome of Board Meeting View filing →
29 July 2026

Results

Unaudited Results For The Quarter Ended June 30, 2026

Unaudited results along with its Limited Review Report for the quarter ended June 30, 2026

Result / Financial Results View filing →
29 July 2026

Investor Presentation

Investor Presentation

Press Release for Unaudited Financial Results for quarter ended June 30, 2026

Company Update / Investor Presentation View filing →
29 July 2026

Press Release

Press Release / Media Release

Press Release for Unaudited Financial results for quarter ended June 30, 2026

Company Update / Press Release / Media Release View filing →
29 July 2026

ESOP Allotment

Allotment of ESOP / ESPS

Intimation for grant of Employee Stock Options

Company Update / Allotment of ESOP / ESPS View filing →
29 July 2026

Record Date

Corporate Action- Record Date: September 04, 2026

Corporate Action- Record Date for dividend Purpose: September 04, 2026

Corp. Action / Record Date View filing →
29 July 2026

Change in Management

Change in Management

Change in Senior Management personnel of the Company

Company Update / Change in Management View filing →
22 July 2026

Board Meeting

Board Meeting Intimation for Prior Intimation Of Board Meeting

Jagsonpal Pharmaceuticals Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/07/2026 ,inter alia, to consider and approve the unaudited Financial ....

Board Meeting / Board Meeting View filing →
22 July 2026

Analyst / Investor Meet

Analyst / Investor Meet - Intimation

Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Company, as a ....

Company Update / Analyst / Investor Meet View filing →
17 July 2026

General

General-Updates

Updates on Acquisition of Aequitas Healthcare Private Limited.

Company Update / General View filing →
15 July 2026

ESOP Allotment

Allotment of ESOP / ESPS

Allotment of 94,000 Equity Shares under the Jagsonpal Pharmaceuticals Limited Employee Stock Option Plan, 2022.

Company Update / Allotment of ESOP / ESPS View filing →